Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Ultrastructural Alteration of Bronchoalveolar Lavage of COVID19 Induced Acute Respiratory Distress Syndrome Patients Reveals the Selective Cellular Infectivity, Impact of Hydroxy-Chloroquine, and Syncytial Formation in the Lung

Yadav et al., American Journal of Respiratory and Critical Care Medicine, doi:10.1164/ajrccm.2025.211.Abstracts.A2672, May 2025
https://c19hcq.org/yadav6.html
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020, now with p < 0.00000000001 from 423 studies, used in 59 countries.
No treatment is 100% effective. Protocols combine treatments.
5,700+ studies for 161 treatments. c19hcq.org
Ultrastructural examination of broncho-alveolar lavage from 79 intubated ARDS patients showing that prior HCQ prophylaxis correlated with markedly fewer intracellular virions, preserved airway cilia, and granulocytes packed with degrading viral remnants, consistent with antiviral activity early in infection. Authors show reduced infection and cellular impairment in ciliated epithelium and type II pneumocytes, and enhanced phagocytic activity in granulocytes, while macrophages and neutrophils were similarly affected in both groups. Results are consistent with clinical studies that show benefits for prophylaxis and early treatment, but poor results with late stage patients. See also Chaudhary et al.
Yadav et al., 18 May 2025, India, peer-reviewed, 2 authors. Contact: subhashmbu@gmail.com.
Ultrastructural Alteration of Bronchoalveolar Lavage of COVID19 Induced Acute Respiratory Distress Syndrome Patients Reveals the Selective Cellular Infectivity, Impact of Hydroxy-Chloroquine, and Syncytial Formation in the Lung
S Yadav, S Chaudhary
This study investigates the effects of SARS-CoV-2 infection on various cell types in the bronchoalveolar fluid (BALF) of intubated COVID-19 patients, focusing on cellular infectivity and ultrastructural changes. We analyzed samples from 79 patients, divided by age (≥60 and <60 years) and common comorbidities (e.g., diabetes, liver and kidney diseases, malignancies). Using light microscopy, immunofluorescence, and electron microscopy, we examined ultrastructural changes in cell types such as ciliated epithelium, type II pneumocytes, macrophages, neutrophils, and granulocytes. The study revealed that younger patients (<60 years) had higher infection rates and better preservation of subcellular structures than older patients (≥60 years). Patients without comorbidities exhibited a higher viral load than those with comorbidities, with diabetic patients showing the most extensive ultrastructural damage among comorbid cases.We also explored the impact of prophylactic hydroxychloroquine (HCQ) on BALF cells in COVID-19-induced acute respiratory distress syndrome (ARDS). Results showed that prophylactic HCQ reduced infection and cellular impairment in ciliated epithelium and type II pneumocytes compared to patients not receiving HCQ, although macrophages and neutrophils were similarly affected in both groups. Granulocytes in the HCQ+ group demonstrated higher phagocytic activity against mature viruses. Immunofluorescence studies revealed high infection levels in syncytial cells. Transmission electron microscopy identified initial fusion of both identical (e.g., neutrophils) and heterotypic (e.g., neutrophils and monocytes) plasma membranes in moderately infected patients. Severe ARDS cases displayed fully mature, large syncytial cells (20-100 µm) originating from neutrophils, monocytes, and macrophages.This study highlights the differential impact of SARS-CoV-2 on BALF cell types in relation to age and comorbidities, along with the paradoxical role of HCQ. The findings provide insight into syncytial cell formation, which progresses from homotypic fusion in type II pneumocytes to heterotypic fusion with hematopoietic cells (e.g., monocytes and neutrophils) during the disease's moderate stage (9-16 days). Mature syncytia emerge in later stages, forming large giant cells (40-100 µm).
DOI record: { "DOI": "10.1164/ajrccm.2025.211.abstracts.a2672", "ISSN": [ "1073-449X", "1535-4970" ], "URL": "http://dx.doi.org/10.1164/ajrccm.2025.211.Abstracts.A2672", "alternative-id": [ "10.1164/ajrccm.2025.211.Abstracts.A2672" ], "assertion": [ { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 3, "value": "2025-05-01" } ], "author": [ { "affiliation": [ { "name": "Electron Microscope Facility, Department of Anatomy, All India Institute of Medical Sciences (AIIMS), New Delhi, India" } ], "family": "Yadav", "given": "S.C.", "sequence": "first" }, { "affiliation": [ { "name": "Electron Microscope Facility, Department of Anatomy, All India Institute of Medical Sciences (AIIMS), New Delhi, India" } ], "family": "Chaudhary", "given": "S.", "sequence": "additional" } ], "container-title": "American Journal of Respiratory and Critical Care Medicine", "container-title-short": "Am J Respir Crit Care Med", "content-domain": { "crossmark-restriction": true, "domain": [ "www.atsjournals.org" ] }, "created": { "date-parts": [ [ 2025, 5, 11 ] ], "date-time": "2025-05-11T14:47:06Z", "timestamp": 1746974826000 }, "deposited": { "date-parts": [ [ 2025, 5, 11 ] ], "date-time": "2025-05-11T14:47:18Z", "timestamp": 1746974838000 }, "indexed": { "date-parts": [ [ 2025, 5, 11 ] ], "date-time": "2025-05-11T15:10:07Z", "timestamp": 1746976207214, "version": "3.40.5" }, "is-referenced-by-count": 0, "issue": "Abstracts", "issued": { "date-parts": [ [ 2025, 5 ] ] }, "journal-issue": { "issue": "Abstracts", "published-print": { "date-parts": [ [ 2025, 5 ] ] } }, "language": "en", "link": [ { "URL": "https://www.atsjournals.org/doi/pdf/10.1164/ajrccm.2025.211.Abstracts.A2672", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "19", "original-title": [], "page": "A2672-A2672", "prefix": "10.1164", "published": { "date-parts": [ [ 2025, 5 ] ] }, "published-print": { "date-parts": [ [ 2025, 5 ] ] }, "publisher": "American Thoracic Society", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://www.atsjournals.org/doi/10.1164/ajrccm.2025.211.Abstracts.A2672" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Ultrastructural Alteration of Bronchoalveolar Lavage of COVID19 Induced Acute Respiratory Distress Syndrome Patients Reveals the Selective Cellular Infectivity, Impact of Hydroxy-Chloroquine, and Syncytial Formation in the Lung", "type": "journal-article", "update-policy": "https://doi.org/10.1164/crossmarkpolicies", "volume": "211" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit